Markets:

Overview

News

Currencies

International

Treasuries

Annexon, Inc. - common stock (NQ:ANNX)

3.680 -0.130 (-3.41%)

Delayed Quote Updated: 12:25 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Annexon, Inc. - common stock

< Previous 1 2 3 4 Next >

Annexon (ANNX) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

GBS and geographic atrophy programs advance toward 2026-2027 regulatory submissions.

Via The Motley Fool

Topics Earnings

Annexon Q2 Earnings Call Highlights ↗

August 12, 2026

Annexon (NASDAQ:ANNX) said it expanded its pivotal ARCHER II trial of vonaprument in geographic atrophy, adding an independent 24-month dual primary endpoint alongside the study’s existing 15-month...

Via MarketBeat

Topics Earnings

Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead ↗

June 09, 2026

Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the...

Via MarketBeat

ANNX Stock Earnings: Annexon Meets EPS for Q2 2024 ↗

August 12, 2024

ANNX stock results show that Annexon met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout ↗

June 04, 2026

Annexon (NASDAQ:ANNX) executives outlined a series of expected clinical and regulatory updates across the company’s complement-focused pipeline during a session at the Jefferies Conference,...

Via MarketBeat

Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference ↗

May 14, 2026

Annexon (NASDAQ:ANNX) President and CEO Doug Love outlined the company’s late-stage pipeline and regulatory plans during a presentation at the Bank of America Healthcare Conference, highlighting...

Via MarketBeat

Biogen Acquires Apellis Pharmaceuticals in $5.6 Billion Deal After Clinical Success

April 01, 2026

In a move that has sent shockwaves through the biotechnology sector, Apellis Pharmaceuticals (Nasdaq: APLS) witnessed an extraordinary 135.7% surge in its share price on March 31, 2026. The massive...

Via MarketMinute

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

January 12, 2026

Via Chartmill

Which stocks are moving on Wednesday? ↗

November 19, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 19, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 14, 2025

Via Benzinga

Annexon Narrows Loss in Fiscal Q2 ↗

August 14, 2025

Via The Motley Fool

Topics Intellectual Property

Thursday's session: gap up and gap down stocks ↗

July 10, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

May 14, 2025

Via Benzinga

Stanley Black & Decker To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

May 13, 2025

Via Benzinga

Annexon's Investigational Drug Shows Rapid Recovery And Durable Benefit In Rare Neurological Disorder ↗

April 09, 2025

Annexon's tanruprubart showed significant and sustained functional gains in Guillain-Barré patients, meeting key Phase 3 trial endpoints.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 17, 2025

Via Benzinga

Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday ↗

July 12, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 10, 2024

Via Benzinga

7 Top Stocks Under $10: June 2024 Edition ↗

June 24, 2024

While blue-chip stocks are great, it's also a good idea to invest in top stocks under $10 to help improve your portfolio's diversification.

Via InvestorPlace

DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 05, 2024

Via Benzinga

Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket ↗

June 05, 2024

Via Benzinga

Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings ↗

June 04, 2024

Via Benzinga

Topics Stocks

Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 04, 2024

Via Benzinga

Mid-Cap Firm Annexon's Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study ↗

June 04, 2024

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disability, muscle strength, and ventilation duration.

Via Benzinga

Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results ↗

June 04, 2024

Via Benzinga

Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday ↗

June 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 04, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 04, 2024

It's time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning!

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.